Cancelled - WEBINAR #6: Fragile X assays on the SeqStudio Genetic Analyzer

Speakers
  • Founder and Director, AdvaGenix
    Biography
      AdvaGenix was founded and is directed by Dr. William G Kearns. Dr. Kearns earned his doctorate at Eastern Virginia Medical School and completed his advanced training during a three-year fellowship in medical genetics at the McKusick-Nathans Institute of Genetic Medicine of The Johns Hopkins University School of Medicine. Dr. Kearns is well known in the field of genetics, particularly preimplantation genetics and cancer genetics, and continues to serve on the faculty of Johns Hopkins in the role of a medical geneticist. He is an associate professor and also trains fellows and graduate students in genetics and reproductive endocrinology from The Johns Hopkins University School of Medicine.
      Dr. Kearns has an international and national reputation in genetics and is uniquely qualified in his ability to devise and implement genetic testing strategies in order to offer IVF patients an opportunity to achieve their goal ... a healthy baby. Dr. Kearns brings important experience to the diagnostic and research laboratory, including his 16 prior years in starting and directing a preimplantation genetic diagnostic company.

    Abstract:
    DATE:  July 26, 2018
    TIME:   8:00am PDT, 11:00am EDT
     

    This is the sixth topic in the webinar series on ‘Sanger Sequencing & Fragment Analysis made easy’.

    In this 30 minute talk, Dr. William G. Kearns, Founder and Director at AdvaGenix will focus on Fragile-X assays and the use of the Applied biosystems SeqStudio Genetic Analyzer in genetic diagnostic applications. He will highlight the main advantages of this capillary electrophoresis (CE)-based platform and share the experience of his team working with the instrument and discuss their results.

    Other topics in the webinar series:

     
     
     

    Show Resources
    Loading Comments...